Neuren Pharmaceuticals has opened the first site for a U.S.-based Phase 2 clinical trial of its investigational therapy NNZ-2591…
Articles by Steve Bryson, PhD
EMO-T, a new emotional skill training program, helped children with Prader-Willi syndrome (PWS) express, recognize, understand, and regulate emotions,…
Reduced activity of the Magel2 gene, which is defective in Prader-Willi syndrome (PWS), specifically in nerve cells that supply…
A Phase 2 study evaluating ARD-101, an investigational, gut-targeting Prader-Willi syndrome (PWS) oral therapy, is now enrolling up to…
Adolescents and adults with Prader-Willi syndrome (PWS) say they struggle with constant hunger and the urge to seek food,…
MRI brain scans of Prader-Willi syndrome (PWS) patients unexpectedly revealed nerve cells in the cerebellum of the brain activated…
In a “significant subset” of  children with Prader-Willi syndrome (PWS), obstructive sleep apnea worsened after the start of growth…
An $11.2-million, five-year grant has been awarded by the Centers of Excellence in Genomic Science of the National Institutes of…
The hunger hormone ghrelin, when measured in infancy, may be a biomarker for predicting the early onset of scoliosis…
Radius Health plans to initiate a Phase 2/3 study to evaluate the safety and efficacy of its investigational therapy…